| Original language | English |
|---|---|
| Pages (from-to) | 425-426 |
| Number of pages | 2 |
| Journal | Clinical Cancer Research |
| Volume | 28 |
| Issue number | 2 |
| DOIs |
|
| Publication status | Published - 15 Jan 2022 |
Bibliographical note
Funding Information:S.I. Buschow reports other support from ISA pharmaceuticals b.v. outside the submitted work. M.P. Peppelenbosch reports grants, personal fees, and non-financial support from Pfizer; grants and personal fees from ZONMW/NWO; and grants from KWF during the conduct of the study; grants from MLDS, CSC, and Wavax; personal fees from NCS, CSF, SNSF, ESF, and Dialecta; grants and personal fees from FWO and European Commission outside the submitted work. M.J. Bruno reports grants and other support from Boston Scientific, Cook Medical, Pentax Medical; grants from Mylan, ChiRoStim, and 3M outside the submitted work. No disclosures were reported by the other authors.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver